Details of the Drug Combinations

General Information of This Drug (ID: DM7NKEV)

Drug Name
Thioguanine   DM7NKEV
Synonyms
6-thioguanine; Lanvis; THG; Tabloid; ThioguaninGSK; Tioguanin; Tioguanina; Tioguanine; Tioguaninum; Glaxo Wellcome Brand of Thioguanine; Glaxo Wellcome Brand of Tioguanine; GlaxoSmithKline Brand of Thioguanine; GlaxoSmithKline Brand of Tioguanine; Thioguanin GSK; Thioguanine Hemihydrate; Thioguanine Monosodium Salt; Thioguanine Tabloid; Tioguanina Wellcome; Tioguanine GlaxoSmithKline Brand; Wellcome Brand of Thioguanine; BW 5071; DX4; LT00455187; Wellcome U3B; Lanvis (TN); Thioguanin-GSK; Thioguanine [USAN:BAN]; Tioguanina[INN-Spanish]; Tioguanine (INN); Tioguaninum [INN-Latin]; Purine antimetabolite: antimetabolite: inhibits nucleic acid replication; Guanine, thio-(VAN); 2 Amino 6 Purinethiol; 2-Amino 6MP; 2-Amino-1,7-dihydro-6H-purin-6-thion; 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]; 2-Amino-1,7-dihydro-6H-purine-6-thione; 2-Amino-6-MP; 2-Amino-6-mercaptopurine; 2-Amino-6-merkaptopurin; 2-Amino-6-merkaptopurin [Czech]; 2-Amino-6-purinethiol; 2-Amino-9H-purine-6-thiol; 2-Aminopurin-6-thiol; 2-Aminopurin-6-thiol [Czech]; 2-Aminopurine-6(1H)-thione; 2-Aminopurine-6-thiol; 2-Thioguanine; 2-amino-3,7-dihydropurine-6-thione; 6 Thioguanine; 6-Mercapto-2-aminopurine; 6-Mercaptoguanine; 6-TG; 6-Thioguanine; 6-Thioguanine (6-TG); 6-Thioguanine, Thioguanine; Thioguanine (Guanine analog)
Indication
Disease Entry ICD 11 Status REF
Acute lymphocytic leukaemia 2B33.3 Approved [1]
Acute myelogenous leukaemia 2A41 Approved [2]
Acute myeloid leukaemia 2A60 Approved [3]
Middle East Respiratory Syndrome (MERS) 1D64 Preclinical [4]
Severe acute respiratory syndrome (SARS) 1D65 Preclinical [4]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

821 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Thioguanine DCWDU0S ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
ABIRATERONE + Thioguanine DC54JZK ABIRATERONE Astrocytoma (Cell Line: U251) [5]
ABIRATERONE + Thioguanine DC83IWQ ABIRATERONE Astrocytoma (Cell Line: SNB-19) [5]
ABIRATERONE + Thioguanine DCS4UNB ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
ABIRATERONE + Thioguanine DC5EU1O ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
ABIRATERONE + Thioguanine DCK2M67 ABIRATERONE Glioblastoma (Cell Line: SNB-75) [5]
ABIRATERONE + Thioguanine DCAA72Z ABIRATERONE Glioma (Cell Line: SF-295) [5]
ABIRATERONE + Thioguanine DCF2ABE ABIRATERONE Renal cell carcinoma (Cell Line: SN12C) [5]
ABIRATERONE + Thioguanine DCUQZDL ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
ABIRATERONE + Thioguanine DC6EH7G ABIRATERONE Carcinoma (Cell Line: RXF 393) [6]
ABIRATERONE + Thioguanine DC3ST12 ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [7]
ABIRATERONE + Thioguanine DCXRKQV ABIRATERONE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
ABIRATERONE + Thioguanine DCONRXO ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
ABIRATERONE + Thioguanine DCCECF8 ABIRATERONE Prostate carcinoma (Cell Line: PC-3) [7]
Amonafide + Thioguanine DCAL3GW Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Amonafide + Thioguanine DCF0SOI Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [5]
Amonafide + Thioguanine DCZNX1J Amonafide Astrocytoma (Cell Line: SNB-19) [5]
Amonafide + Thioguanine DCCFB1M Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Amonafide + Thioguanine DC07G7Z Amonafide Glioma (Cell Line: SF-268) [5]
Amonafide + Thioguanine DCQE1A8 Amonafide Glioma (Cell Line: SF-539) [5]
Amonafide + Thioguanine DCXKLGV Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Amonafide + Thioguanine DCK63Z7 Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [5]
Amonafide + Thioguanine DCNPQW0 Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Amonafide + Thioguanine DCTNFE1 Amonafide Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Amonafide + Thioguanine DCY7DHJ Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Amonafide + Thioguanine DC9HLSK Amonafide Carcinoma (Cell Line: RXF 393) [6]
Amonafide + Thioguanine DCBPC48 Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [6]
Anastrozole + Thioguanine DCVV1GZ Anastrozole Adenocarcinoma (Cell Line: NCIH23) [5]
Anastrozole + Thioguanine DC8XSQU Anastrozole Adenocarcinoma (Cell Line: HCT116) [5]
Anastrozole + Thioguanine DCJHPNU Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Anastrozole + Thioguanine DCH9XBO Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [5]
Anastrozole + Thioguanine DCM1K34 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [5]
Anastrozole + Thioguanine DC9S8AM Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Anastrozole + Thioguanine DCX8A0B Anastrozole Glioma (Cell Line: SF-268) [5]
Anastrozole + Thioguanine DC1UERH Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Anastrozole + Thioguanine DCACI6P Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Anastrozole + Thioguanine DCR6Q6T Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [5]
Anastrozole + Thioguanine DCL9CR5 Anastrozole Melanoma (Cell Line: UACC-257) [5]
Anastrozole + Thioguanine DC8KJ0D Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Anastrozole + Thioguanine DC3GEF4 Anastrozole Prostate carcinoma (Cell Line: PC-3) [5]
Anastrozole + Thioguanine DC56UWD Anastrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Anastrozole + Thioguanine DCU1GZQ Anastrozole Carcinoma (Cell Line: RXF 393) [6]
Anastrozole + Thioguanine DCOSP9K Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [6]
Anastrozole + Thioguanine DCPD4AD Anastrozole Colon carcinoma (Cell Line: KM12) [6]
BIO-300 + Thioguanine DCIV4ST BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
BIO-300 + Thioguanine DCO6XQY BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
BIO-300 + Thioguanine DCMHAKE BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [5]
BIO-300 + Thioguanine DCPSDD4 BIO-300 Astrocytoma (Cell Line: SNB-19) [5]
BIO-300 + Thioguanine DCVCO0A BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
BIO-300 + Thioguanine DC2YL57 BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [5]
BIO-300 + Thioguanine DCJWGPG BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
BIO-300 + Thioguanine DCGJMR6 BIO-300 Glioblastoma (Cell Line: SNB-75) [5]
BIO-300 + Thioguanine DCI0RCL BIO-300 Glioma (Cell Line: SF-295) [5]
BIO-300 + Thioguanine DC5K75Y BIO-300 Glioma (Cell Line: SF-268) [5]
BIO-300 + Thioguanine DC0EGBI BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [5]
BIO-300 + Thioguanine DCS6W7D BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [6]
BIO-300 + Thioguanine DC3681I BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [7]
BIO-300 + Thioguanine DC3AQBQ BIO-300 Melanoma (Cell Line: SK-MEL-2) [7]
Bleomycin + Thioguanine DCG9PGF Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Bleomycin + Thioguanine DCMMBL5 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Bleomycin + Thioguanine DCZPNDG Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Bleomycin + Thioguanine DCEYOBA Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Bleomycin + Thioguanine DC93VD1 Bleomycin Glioblastoma (Cell Line: SNB-75) [5]
Bleomycin + Thioguanine DCX3ZNP Bleomycin Glioma (Cell Line: SF-268) [5]
Bleomycin + Thioguanine DCNZ7XA Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Bleomycin + Thioguanine DC9YGPN Bleomycin Renal cell carcinoma (Cell Line: SN12C) [5]
Bleomycin + Thioguanine DCCADC7 Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Bleomycin + Thioguanine DCC5QOG Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Bleomycin + Thioguanine DCXXL8P Bleomycin Colon carcinoma (Cell Line: KM12) [6]
Bleomycin + Thioguanine DCD6PWO Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Bleomycin + Thioguanine DC65PZ9 Bleomycin Adenocarcinoma (Cell Line: SW-620) [7]
Bleomycin + Thioguanine DCOU7CJ Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Bleomycin + Thioguanine DCY2XLW Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Bleomycin + Thioguanine DCU2OEZ Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [7]
Bleomycin + Thioguanine DC46K49 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [7]
Bleomycin + Thioguanine DC9SK92 Bleomycin Melanoma (Cell Line: SK-MEL-2) [7]
Bleomycin + Thioguanine DC1UVZV Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Cabazitaxel + Thioguanine DCJ3WTV Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [5]
Cabazitaxel + Thioguanine DC7YHGP Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [5]
Cabazitaxel + Thioguanine DCXAA9Z Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Cabazitaxel + Thioguanine DCK7OSQ Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Cabazitaxel + Thioguanine DCWTKGK Cabazitaxel Astrocytoma (Cell Line: SNB-19) [5]
Cabazitaxel + Thioguanine DCDU9B9 Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Cabazitaxel + Thioguanine DCSMQXN Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Cabazitaxel + Thioguanine DCELTPN Cabazitaxel Glioblastoma (Cell Line: SNB-75) [5]
Cabazitaxel + Thioguanine DCRMT68 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Cabazitaxel + Thioguanine DC988GF Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Cabazitaxel + Thioguanine DC3QTF6 Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [5]
Cabazitaxel + Thioguanine DC2635Q Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Cabazitaxel + Thioguanine DCDW7QO Cabazitaxel Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Cabazitaxel + Thioguanine DCMSYKF Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [5]
Crizotinib + Thioguanine DCSKFN0 Crizotinib Adenocarcinoma (Cell Line: DU-145) [5]
Crizotinib + Thioguanine DCQXLE6 Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [5]
Crizotinib + Thioguanine DC9SG81 Crizotinib Adenocarcinoma (Cell Line: NCIH23) [5]
Crizotinib + Thioguanine DCVF4ZT Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Crizotinib + Thioguanine DC8M6N5 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Crizotinib + Thioguanine DCHMUQJ Crizotinib Astrocytoma (Cell Line: U251) [5]
Crizotinib + Thioguanine DCLPWME Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Crizotinib + Thioguanine DCF6WCE Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Crizotinib + Thioguanine DC5CVPM Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Crizotinib + Thioguanine DCRDAA1 Crizotinib Glioma (Cell Line: SF-539) [5]
Crizotinib + Thioguanine DCURH2M Crizotinib Glioma (Cell Line: SF-295) [5]
Crizotinib + Thioguanine DCEM0EB Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Crizotinib + Thioguanine DCKA0EQ Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Crizotinib + Thioguanine DC7L6G7 Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Crizotinib + Thioguanine DC2BNUZ Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Crizotinib + Thioguanine DCZHL5C Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Crizotinib + Thioguanine DCWAPW6 Crizotinib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Crizotinib + Thioguanine DCLEPV3 Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Crizotinib + Thioguanine DCJARS0 Crizotinib Renal cell carcinoma (Cell Line: SN12C) [5]
Crizotinib + Thioguanine DCXGVBM Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Crizotinib + Thioguanine DC1IBTV Crizotinib Carcinoma (Cell Line: MCF7) [6]
Crizotinib + Thioguanine DC9VSKD Crizotinib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Crizotinib + Thioguanine DCFZXYY Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Dacarbazine + Thioguanine DCI1RJL Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dacarbazine + Thioguanine DCVY9PV Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dacarbazine + Thioguanine DC3YK7M Dacarbazine Astrocytoma (Cell Line: SNB-19) [5]
Dacarbazine + Thioguanine DCVB9OC Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dacarbazine + Thioguanine DC8AF8G Dacarbazine Glioma (Cell Line: SF-268) [5]
Dacarbazine + Thioguanine DCZ6ISJ Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Dacarbazine + Thioguanine DCHUKBX Dacarbazine Melanoma (Cell Line: SK-MEL-2) [5]
Dacarbazine + Thioguanine DCHLYVQ Dacarbazine Renal cell carcinoma (Cell Line: SN12C) [5]
Dacarbazine + Thioguanine DC767LE Dacarbazine Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Dacarbazine + Thioguanine DC32SV2 Dacarbazine Carcinoma (Cell Line: RXF 393) [6]
Dacarbazine + Thioguanine DCFJHN5 Dacarbazine Colon adenocarcinoma (Cell Line: COLO 205) [6]
Dexrazoxane + Thioguanine DCFF846 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Thioguanine DCRZ9QZ Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Thioguanine DC3F1DV Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Thioguanine DCLVNX3 Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Thioguanine DCVKRR0 Dexrazoxane Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Thioguanine DCHRYH5 Dexrazoxane Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + Thioguanine DC1QQZG Dexrazoxane Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Thioguanine DCU0PJ7 Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Thioguanine DC5AO6U Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Dexrazoxane + Thioguanine DCO7R0J Dexrazoxane Carcinoma (Cell Line: RXF 393) [6]
Dexrazoxane + Thioguanine DCBUHU8 Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [6]
Dexrazoxane + Thioguanine DC3RYFP Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Dexrazoxane + Thioguanine DCXCT2G Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Dexrazoxane + Thioguanine DC60QNN Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Dexrazoxane + Thioguanine DCQ6SRQ Dexrazoxane Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Epirubicin + Thioguanine DCJL2RX Epirubicin Astrocytoma (Cell Line: SNB-19) [5]
Epirubicin + Thioguanine DCND261 Epirubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Epirubicin + Thioguanine DCN1Q9Q Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Epirubicin + Thioguanine DC12B8P Epirubicin Glioblastoma (Cell Line: SNB-75) [5]
Epirubicin + Thioguanine DC9OVS2 Epirubicin Glioma (Cell Line: SF-295) [5]
Epirubicin + Thioguanine DCKTWBY Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Epirubicin + Thioguanine DCDFK7K Epirubicin Renal cell carcinoma (Cell Line: SN12C) [5]
Epirubicin + Thioguanine DC80TY3 Epirubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Epirubicin + Thioguanine DC2GF04 Epirubicin Carcinoma (Cell Line: RXF 393) [6]
Epirubicin + Thioguanine DCV6TKC Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Epirubicin + Thioguanine DCFZ9O2 Epirubicin Adenocarcinoma (Cell Line: DU-145) [7]
Epirubicin + Thioguanine DC48K9P Epirubicin Prostate carcinoma (Cell Line: PC-3) [7]
Gefitinib + Thioguanine DC1O3X0 Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Gefitinib + Thioguanine DCRYUTV Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Gefitinib + Thioguanine DCHQESV Gefitinib Astrocytoma (Cell Line: SNB-19) [5]
Gefitinib + Thioguanine DC9IXWR Gefitinib Glioma (Cell Line: SF-268) [5]
Gefitinib + Thioguanine DCBHOQS Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Gefitinib + Thioguanine DCWP8CM Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Gefitinib + Thioguanine DCWTR6F Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Gefitinib + Thioguanine DCPUEZY Gefitinib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Indazole derivative 5 + Thioguanine DCCZA55 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Indazole derivative 5 + Thioguanine DCKFD6H Indazole derivative 5 Astrocytoma (Cell Line: U251) [5]
Indazole derivative 5 + Thioguanine DCXQ9RK Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [5]
Indazole derivative 5 + Thioguanine DC095FR Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Indazole derivative 5 + Thioguanine DC6727M Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Indazole derivative 5 + Thioguanine DC0E3EP Indazole derivative 5 Glioblastoma (Cell Line: SNB-75) [5]
Indazole derivative 5 + Thioguanine DCVZXXR Indazole derivative 5 Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Indazole derivative 5 + Thioguanine DCHVG4J Indazole derivative 5 Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Indazole derivative 5 + Thioguanine DC1T9VM Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [5]
Indazole derivative 5 + Thioguanine DCQ5YCI Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Indazole derivative 5 + Thioguanine DC6E323 Indazole derivative 5 Carcinoma (Cell Line: MCF7) [6]
Indazole derivative 5 + Thioguanine DCBWA7G Indazole derivative 5 Colon adenocarcinoma (Cell Line: COLO 205) [6]
Indazole derivative 5 + Thioguanine DCAZAEC Indazole derivative 5 Adenocarcinoma (Cell Line: DU-145) [7]
Indazole derivative 5 + Thioguanine DC5CSZQ Indazole derivative 5 Adenocarcinoma (Cell Line: NCIH23) [7]
Indazole derivative 5 + Thioguanine DCW28K1 Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Indazole derivative 5 + Thioguanine DC2BG9R Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Indazole derivative 5 + Thioguanine DCMUGY7 Indazole derivative 5 Malignant melanoma (Cell Line: LOX IMVI) [7]
Indazole derivative 5 + Thioguanine DCR2P4D Indazole derivative 5 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Lenalidomide + Thioguanine DC9TF8U Lenalidomide Anaplastic large cell lymphoma (Cell Line: SR) [5]
Lenalidomide + Thioguanine DCEY8PY Lenalidomide Carcinoma (Cell Line: RXF 393) [6]
Mechlorethamine + Thioguanine DCEZL9R Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Mechlorethamine + Thioguanine DCRN3XI Mechlorethamine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Mechlorethamine + Thioguanine DCX8AHY Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [6]
Mechlorethamine + Thioguanine DCT2JVH Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Mechlorethamine + Thioguanine DC30CKD Mechlorethamine Adenocarcinoma (Cell Line: OVCAR3) [7]
Mechlorethamine + Thioguanine DCGJCCT Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [7]
Mechlorethamine + Thioguanine DC74JFW Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [7]
Mechlorethamine + Thioguanine DC2OVLQ Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [7]
Mechlorethamine + Thioguanine DCPX91S Mechlorethamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Mechlorethamine + Thioguanine DCXVPGH Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Mechlorethamine + Thioguanine DCDXMT2 Mechlorethamine Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Mechlorethamine + Thioguanine DCZEDC2 Mechlorethamine Prostate carcinoma (Cell Line: PC-3) [7]
Raloxifene + Thioguanine DC2N1P9 Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Raloxifene + Thioguanine DC2L97W Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [5]
Raloxifene + Thioguanine DCJLQ54 Raloxifene Astrocytoma (Cell Line: U251) [5]
Raloxifene + Thioguanine DCN1GAV Raloxifene Astrocytoma (Cell Line: SNB-19) [5]
Raloxifene + Thioguanine DCLV1C1 Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Raloxifene + Thioguanine DCBT6UY Raloxifene Chronic myelogenous leukemia (Cell Line: K-562) [5]
Raloxifene + Thioguanine DCUJ467 Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Raloxifene + Thioguanine DC4P03U Raloxifene Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Raloxifene + Thioguanine DCO82S6 Raloxifene Glioblastoma (Cell Line: SNB-75) [5]
Raloxifene + Thioguanine DCCVYC9 Raloxifene Glioma (Cell Line: SF-295) [5]
Raloxifene + Thioguanine DCVWYMS Raloxifene Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Raloxifene + Thioguanine DCC8KZQ Raloxifene Renal cell carcinoma (Cell Line: SN12C) [5]
Raloxifene + Thioguanine DCC2G6W Raloxifene Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Raloxifene + Thioguanine DCI8OSF Raloxifene Carcinoma (Cell Line: RXF 393) [6]
Raloxifene + Thioguanine DC2NRLP Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [6]
Raloxifene + Thioguanine DC6JYMM Raloxifene Adenocarcinoma (Cell Line: HCT-15) [7]
Raloxifene + Thioguanine DCTC5DH Raloxifene Adenocarcinoma (Cell Line: HCT116) [7]
Raloxifene + Thioguanine DCXU1CP Raloxifene Adenocarcinoma (Cell Line: SW-620) [7]
Raloxifene + Thioguanine DC7FD0B Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Raloxifene + Thioguanine DC60A57 Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Raloxifene + Thioguanine DCNYHU0 Raloxifene Lung adenocarcinoma (Cell Line: HOP-62) [7]
Raloxifene + Thioguanine DCNIUKH Raloxifene Malignant melanoma (Cell Line: LOX IMVI) [7]
Raloxifene + Thioguanine DCWHQNU Raloxifene Prostate carcinoma (Cell Line: PC-3) [7]
Ruxolitinib + Thioguanine DCQLJ3S Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Ruxolitinib + Thioguanine DC0UB9C Ruxolitinib Astrocytoma (Cell Line: SNB-19) [5]
Ruxolitinib + Thioguanine DCIMAZ1 Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Ruxolitinib + Thioguanine DCWRIIN Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Ruxolitinib + Thioguanine DC4O4IJ Ruxolitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Ruxolitinib + Thioguanine DCDD9GJ Ruxolitinib Glioma (Cell Line: SF-295) [5]
Ruxolitinib + Thioguanine DC62QJ5 Ruxolitinib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Ruxolitinib + Thioguanine DCPOKV3 Ruxolitinib Renal cell carcinoma (Cell Line: SN12C) [5]
Ruxolitinib + Thioguanine DCIK0CV Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Ruxolitinib + Thioguanine DCT9FT6 Ruxolitinib Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Ruxolitinib + Thioguanine DCI2HA0 Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [7]
Ruxolitinib + Thioguanine DCSWOC4 Ruxolitinib Lung adenocarcinoma (Cell Line: EKVX) [7]
Ruxolitinib + Thioguanine DCU5MEN Ruxolitinib Malignant melanoma (Cell Line: LOX IMVI) [7]
Ruxolitinib + Thioguanine DCWCZMJ Ruxolitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Thioguanine + Pentostatin DCK3BWU Pentostatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Picoplatin DCKQO06 Picoplatin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Fulvestrant DCORW1R Fulvestrant Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Fulvestrant DCH2DGM Fulvestrant Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Fulvestrant DCSZAIT Fulvestrant Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Fulvestrant DC80W0N Fulvestrant Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Hepzato DC15IJ3 Hepzato Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Hepzato DCVDQFH Hepzato Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Ixabepilone DCMA3BL Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Ixabepilone DCZ8G0S Ixabepilone Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Ixabepilone DCCVCU9 Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Ixabepilone DCSVITX Ixabepilone Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Ixabepilone DCEVC0W Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Ixabepilone DC9R2P9 Ixabepilone Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Ixabepilone DCIN5VQ Ixabepilone Glioma (Cell Line: SF-295) [5]
Thioguanine + Dactinomycin DCL81ZX Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Dactinomycin DCOLTJZ Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Dactinomycin DCQGH3A Dactinomycin Glioma (Cell Line: SF-268) [5]
Thioguanine + Dactinomycin DCNV1EE Dactinomycin Glioma (Cell Line: SF-539) [5]
Thioguanine + Dactinomycin DCWRHT4 Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Dactinomycin DCG5NEH Dactinomycin Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + DFN-15 DC1N0M2 DFN-15 Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Lapatinib DCUNJG8 Lapatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Lapatinib DC2DDDL Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Lapatinib DCMOM38 Lapatinib Astrocytoma (Cell Line: U251) [5]
Thioguanine + Lapatinib DCEDA4O Lapatinib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Lapatinib DCJIZFX Lapatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Lapatinib DC578HS Lapatinib Glioma (Cell Line: SF-539) [5]
Thioguanine + Lapatinib DC8EFUE Lapatinib Glioma (Cell Line: SF-295) [5]
Thioguanine + PMID28460551-Compound-2 DCJHSZV PMID28460551-Compound-2 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + PMID28460551-Compound-2 DC4ZDZR PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + PMID28460551-Compound-2 DCS2G4Y PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + PMID28460551-Compound-2 DCSN017 PMID28460551-Compound-2 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + PMID28460551-Compound-2 DCO9HHO PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Crizotinib DCU1CBL Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Crizotinib DCREDHZ Crizotinib Glioma (Cell Line: SF-295) [5]
Thioguanine + Cyclophosphamide DCIPJZ4 Cyclophosphamide Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Methotrexate DCFSMN2 Methotrexate Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Methotrexate DC375FB Methotrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Methotrexate DC0AP08 Methotrexate Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Methotrexate DCYLDX2 Methotrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Methotrexate DCK20TQ Methotrexate Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Methotrexate DC0PWKS Methotrexate Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Methotrexate DC9FVJR Methotrexate Glioma (Cell Line: SF-268) [5]
Thioguanine + Methotrexate DCZV0O7 Methotrexate Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Methotrexate DC4RAO1 Methotrexate Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Vemurafenib DCG4KXC Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Vemurafenib DCZ73D6 Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Vemurafenib DCJTOB8 Vemurafenib Glioma (Cell Line: SF-295) [5]
Thioguanine + Plicamycin DCYS8YP Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Plicamycin DC26IKP Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Plicamycin DCHB204 Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Plicamycin DCFV82K Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Plicamycin DCQN5TX Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Plicamycin DC9G5VL Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Plicamycin DCONS86 Plicamycin Glioma (Cell Line: SF-268) [5]
Thioguanine + Plicamycin DCVGRT7 Plicamycin Glioma (Cell Line: SF-539) [5]
Thioguanine + Plicamycin DCHE0MO Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Plicamycin DCU0MML Plicamycin Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Plicamycin DCLYTBH Plicamycin Renal cell carcinoma (Cell Line: UO-31) [5]
Thioguanine + Nilotinib DCOQIBF Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Nilotinib DCBKKP2 Nilotinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Nilotinib DCXIS0R Nilotinib Astrocytoma (Cell Line: U251) [5]
Thioguanine + Nilotinib DC7JKYO Nilotinib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Nilotinib DCHVGD4 Nilotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Nilotinib DCICOQB Nilotinib Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Nilotinib DCQ3KIC Nilotinib Glioma (Cell Line: SF-539) [5]
Thioguanine + Nilotinib DCFZD4I Nilotinib Glioma (Cell Line: SF-295) [5]
Thioguanine + 10-hydroxycamptothecin DCMMX0S 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + 10-hydroxycamptothecin DCZOF2P 10-hydroxycamptothecin Glioma (Cell Line: SF-295) [5]
Thioguanine + Topetecan DC7QO5G Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Topetecan DCG7RUR Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Topetecan DCYM3LY Topetecan Astrocytoma (Cell Line: U251) [5]
Thioguanine + Topetecan DCX00TP Topetecan Glioma (Cell Line: SF-295) [5]
Thioguanine + Pralatrexate DCXG8QG Pralatrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Pralatrexate DCGRHUF Pralatrexate Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Pralatrexate DCQAH30 Pralatrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Pralatrexate DC04OM5 Pralatrexate Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Pralatrexate DCNCG5S Pralatrexate Glioma (Cell Line: SF-295) [5]
Thioguanine + SCH 727965 DCPH6YF SCH 727965 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + SCH 727965 DCKITK8 SCH 727965 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + SCH 727965 DCPIJ2G SCH 727965 Astrocytoma (Cell Line: U251) [5]
Thioguanine + SCH 727965 DCDHWEJ SCH 727965 Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + SCH 727965 DC8LGXH SCH 727965 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + SCH 727965 DCY47EG SCH 727965 Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + SCH 727965 DCW6I6D SCH 727965 Glioma (Cell Line: SF-295) [5]
Thioguanine + Raloxifene DCNM9OV Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Raloxifene DCF7YZE Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Raloxifene DCZSRL6 Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Raloxifene DCUH0WK Raloxifene Clear cell renal cell carcinoma (Cell Line: A498) [5]
Thioguanine + Raloxifene DCTXREW Raloxifene Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Bendamustine hydrochloride DCJSRS2 Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Bendamustine hydrochloride DCV92UI Bendamustine hydrochloride Glioma (Cell Line: SF-539) [5]
Thioguanine + Bendamustine hydrochloride DCYQHPS Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Sirolimus DCXEQH0 Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Sirolimus DC51ICH Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Letrozole DC0ABS5 Letrozole Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Mitomycin DCTZE9Z Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Mitomycin DCIZ70H Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Mitomycin DCNC0JK Mitomycin Astrocytoma (Cell Line: U251) [5]
Thioguanine + Mitomycin DCQ6ELF Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Mitomycin DC0BW0W Mitomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Mitomycin DC7NTQT Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Mitomycin DC2WZZE Mitomycin Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + SY-1425 DC1M0RM SY-1425 Glioma (Cell Line: SF-539) [5]
Thioguanine + SY-1425 DCUQGDE SY-1425 Glioma (Cell Line: SF-295) [5]
Thioguanine + Vincristine DC6GEYF Vincristine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Vincristine DCVBM2B Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Vincristine DCUMSR6 Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Vincristine DCV5SNH Vincristine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Vincristine DC5QG4P Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Vincristine DC784KE Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [5]
Thioguanine + Vincristine DCQ2JU8 Vincristine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Vincristine DCGHNZD Vincristine Glioma (Cell Line: SF-295) [5]
Thioguanine + Vincristine DCAEDRB Vincristine Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Vincristine DC6LHLZ Vincristine Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Arfolitixorin DC6YOB8 Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Arfolitixorin DCO4YXO Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Arfolitixorin DCXXSQ6 Arfolitixorin Astrocytoma (Cell Line: U251) [5]
Thioguanine + Arfolitixorin DCSJCQR Arfolitixorin Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Arfolitixorin DC19546 Arfolitixorin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Arfolitixorin DCWHAAT Arfolitixorin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Arfolitixorin DCIGQ3S Arfolitixorin Glioma (Cell Line: SF-268) [5]
Thioguanine + Arfolitixorin DCC366W Arfolitixorin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Arfolitixorin DCN7H2H Arfolitixorin Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Altretamine DCKREBZ Altretamine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + JNK-IN-8 DCZ7POI JNK-IN-8 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + JNK-IN-8 DCUT1BC JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + JNK-IN-8 DCTIVH8 JNK-IN-8 Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + JNK-IN-8 DC0UH06 JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + JNK-IN-8 DC1ZTTT JNK-IN-8 Glioma (Cell Line: SF-295) [5]
Thioguanine + Idarubicin DCT8I8Q Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Idarubicin DCYRC59 Idarubicin Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Idarubicin DC0OQDF Idarubicin Glioma (Cell Line: SF-539) [5]
Thioguanine + Idarubicin DCS9WXE Idarubicin Glioma (Cell Line: SF-295) [5]
Thioguanine + Imatinib DCF2KQ8 Imatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Imatinib DC6HRCN Imatinib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Imatinib DCBVO3J Imatinib Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Imatinib DCS3RLQ Imatinib Glioma (Cell Line: SF-295) [5]
Thioguanine + Bleomycin DCB1S7W Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Bleomycin DCUCX77 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Bleomycin DCVG1Y0 Bleomycin Astrocytoma (Cell Line: U251) [5]
Thioguanine + Bleomycin DCWXLZZ Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Bleomycin DCO497D Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Bleomycin DCT7QZS Bleomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Bleomycin DCTNR2E Bleomycin Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Bleomycin DCXA8OV Bleomycin Glioma (Cell Line: SF-268) [5]
Thioguanine + Bleomycin DCNU84W Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Bleomycin DCP66T0 Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Bortezomib DC5DXG5 Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Bortezomib DCB2TTK Bortezomib Glioma (Cell Line: SF-295) [5]
Thioguanine + Valrubicin DC1MSFP Valrubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Valrubicin DC4LO9M Valrubicin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Topotecan DCR36KB Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Topotecan DCUXBB1 Topotecan Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Topotecan DCO6FK3 Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Topotecan DCCCKQN Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Topotecan DCV8MK2 Topotecan Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Topotecan DCLP4SC Topotecan Glioma (Cell Line: SF-268) [5]
Thioguanine + Topotecan DCT8MFN Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Topotecan DCNM71M Topotecan Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Chlorambucil DCRQCVA Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Chlorambucil DCVXYEO Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Chlorambucil DCB2BC4 Chlorambucil Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Chlorambucil DC0I6H1 Chlorambucil Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Chlorambucil DCQZSDF Chlorambucil Glioma (Cell Line: SF-295) [5]
Thioguanine + Sorafenib DC0U696 Sorafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Sorafenib DCMEW3I Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Sorafenib DCHIX5J Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Sorafenib DCU93HQ Sorafenib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Sorafenib DCNZXDY Sorafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Sorafenib DCSYMXC Sorafenib Glioma (Cell Line: SF-295) [5]
Thioguanine + ER819762 DCXA46J ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + ER819762 DCARX4O ER819762 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + ER819762 DCSXKS9 ER819762 Astrocytoma (Cell Line: U251) [5]
Thioguanine + ER819762 DC98MLH ER819762 Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + ER819762 DCRZS5G ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + ER819762 DCP72SB ER819762 Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + ER819762 DCB6SC8 ER819762 Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + ER819762 DCR4444 ER819762 Glioma (Cell Line: SF-539) [5]
Thioguanine + ER819762 DC9IUI4 ER819762 Glioma (Cell Line: SF-295) [5]
Thioguanine + ER819762 DCQE367 ER819762 Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Romidepsin DCGXTKB Romidepsin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Romidepsin DC3BBPT Romidepsin Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Romidepsin DC76X7Q Romidepsin Glioma (Cell Line: SF-295) [5]
Thioguanine + Azacitidine DCGN2H9 Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Azacitidine DC04BJA Azacitidine Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Azacitidine DCSFO93 Azacitidine Glioma (Cell Line: SF-295) [5]
Thioguanine + Azacitidine DC1ALVA Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Pomalidomide DC2BJHM Pomalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Pomalidomide DC9MLLQ Pomalidomide Glioma (Cell Line: SF-295) [5]
Thioguanine + Pomalidomide DCSTFUH Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Vinflunine DC5TQAT Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Mercaptopurine DC5VWHV Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Taxol DC0KWUB Taxol Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Taxol DCC8JF4 Taxol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Taxol DCWKC6K Taxol Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Taxol DCB3D4J Taxol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Thioguanine + Fludarabine DCYQZQG Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + FORMESTANE DCS06J3 FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + FORMESTANE DCE3DX4 FORMESTANE Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + FORMESTANE DCMJX8A FORMESTANE Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCF4TXI Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCHBK8K Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCU4CR1 Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCH6X5T Aminolevulinic Acid Hydrochloride Astrocytoma (Cell Line: U251) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCWF2K0 Aminolevulinic Acid Hydrochloride Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCMSYKV Aminolevulinic Acid Hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCOQM3I Aminolevulinic Acid Hydrochloride Clear cell renal cell carcinoma (Cell Line: A498) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DC5S5WD Aminolevulinic Acid Hydrochloride Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCNB60X Aminolevulinic Acid Hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCB1AY8 Aminolevulinic Acid Hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Thioguanine + Aminolevulinic Acid Hydrochloride DCH6A5K Aminolevulinic Acid Hydrochloride Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Estramustine DCKR4G9 Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Estramustine DCWJ3EG Estramustine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Digitoxin DCJXNV2 Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Digitoxin DC1GAOS Digitoxin Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Digitoxin DC7Q6R1 Digitoxin Glioma (Cell Line: SF-295) [5]
Thioguanine + Busulfan DCLW6ZP Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Busulfan DCH4K6P Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Busulfan DC0F938 Busulfan Glioma (Cell Line: SF-539) [5]
Thioguanine + Busulfan DCIL8G1 Busulfan Glioma (Cell Line: SF-268) [5]
Thioguanine + Busulfan DCBU08O Busulfan Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Dasatinib DC0L22V Dasatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Thioguanine + Dasatinib DC265TP Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Thioguanine + Dasatinib DCXIK11 Dasatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Thioguanine + Dasatinib DCRXUFM Dasatinib Astrocytoma (Cell Line: U251) [5]
Thioguanine + Dasatinib DCF9S0G Dasatinib Astrocytoma (Cell Line: SNB-19) [5]
Thioguanine + Dasatinib DCXTUGZ Dasatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Thioguanine + Dasatinib DCAO5KS Dasatinib Chronic myelogenous leukemia (Cell Line: K-562) [5]
Thioguanine + Dasatinib DC799XW Dasatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Thioguanine + Dasatinib DC87694 Dasatinib Glioblastoma (Cell Line: SNB-75) [5]
Thioguanine + Dasatinib DC5SR7K Dasatinib Glioma (Cell Line: SF-539) [5]
Thioguanine + Dasatinib DCQBE8A Dasatinib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Thioguanine + Dasatinib DC39CXJ Dasatinib Renal cell carcinoma (Cell Line: SN12C) [5]
Thioguanine + Fulvestrant DCSV01F Fulvestrant Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Hepzato DCVM8CM Hepzato Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Thioguanine + Ixabepilone DCI7XAD Ixabepilone Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Dactinomycin DCLOTJB Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Lapatinib DCYJFHG Lapatinib Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Lapatinib DCHQDQ5 Lapatinib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + PMID28460551-Compound-2 DCQ6L6G PMID28460551-Compound-2 Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + PMID28460551-Compound-2 DCP60IR PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [6]
Thioguanine + PMID28460551-Compound-2 DCWROCZ PMID28460551-Compound-2 Carcinoma (Cell Line: MCF7) [6]
Thioguanine + PMID28460551-Compound-2 DC2BAY8 PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + PMID28460551-Compound-2 DCW4E6O PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [6]
Thioguanine + PMID28460551-Compound-2 DCOK7BT PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + PMID28460551-Compound-2 DCI46MF PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: T-47D) [6]
Thioguanine + Methotrexate DCZS4C9 Methotrexate Invasive ductal carcinoma (Cell Line: T-47D) [6]
Thioguanine + Isoniazid DC2G2X4 Isoniazid Colon carcinoma (Cell Line: KM12) [6]
Thioguanine + Vemurafenib DC3TE9T Vemurafenib Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Vemurafenib DC1VTR3 Vemurafenib Colon carcinoma (Cell Line: KM12) [6]
Thioguanine + Plicamycin DCRLIJ9 Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Plicamycin DCH7VUS Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Thioguanine + Nilotinib DCXBU7J Nilotinib Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Pralatrexate DCNY84B Pralatrexate Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Ifosfamide DCUQXFZ Ifosfamide Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Raloxifene DCZBTW6 Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Sirolimus DC14BY5 Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Letrozole DCOCZU8 Letrozole Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Thioguanine + Mitomycin DC2V2MG Mitomycin Carcinoma (Cell Line: RXF 393) [6]
Thioguanine + Mitomycin DC45A94 Mitomycin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Mitomycin DCZ99S5 Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Thioguanine + Mitomycin DCFKMIK Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + SY-1425 DC51Z44 SY-1425 Colon carcinoma (Cell Line: KM12) [6]
Thioguanine + Arfolitixorin DCNJXQF Arfolitixorin Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Arfolitixorin DCMUFZB Arfolitixorin Carcinoma (Cell Line: RXF 393) [6]
Thioguanine + Arfolitixorin DCCTD05 Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + JNK-IN-8 DC5XQBZ JNK-IN-8 Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Bleomycin DCUF4Q1 Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Bleomycin DCHY3XY Bleomycin Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Bleomycin DCULA3B Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Bortezomib DCPPBWV Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Valrubicin DCCFXHU Valrubicin Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Topotecan DCMBPK1 Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Topotecan DC8KWT6 Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Thioguanine + Chlorambucil DCHUDB6 Chlorambucil Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Chlorambucil DCKEV10 Chlorambucil Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + ER819762 DCSARWU ER819762 Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + ER819762 DCDCZTR ER819762 Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + ER819762 DCYAVA8 ER819762 Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Romidepsin DCURW51 Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Azacitidine DCJ7TST Azacitidine Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Pomalidomide DC7LYF1 Pomalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Pomalidomide DCD65N0 Pomalidomide Colon carcinoma (Cell Line: KM12) [6]
Thioguanine + Taxol DCW74HT Taxol Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Aminolevulinic Acid Hydrochloride DCR3QLE Aminolevulinic Acid Hydrochloride Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Aminolevulinic Acid Hydrochloride DCSP9NQ Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [6]
Thioguanine + Dasatinib DCT7JA4 Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Thioguanine + Dasatinib DC402Q7 Dasatinib Carcinoma (Cell Line: MCF7) [6]
Thioguanine + Dasatinib DCA9V3J Dasatinib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Thioguanine + Picoplatin DC98CXA Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Fulvestrant DC6EYVZ Fulvestrant Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Fulvestrant DC0EWZ7 Fulvestrant Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Fulvestrant DC2FG06 Fulvestrant Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Thioguanine + Fulvestrant DCNH573 Fulvestrant Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + Fulvestrant DCDW6NC Fulvestrant Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + Hepzato DCQN45A Hepzato Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Hepzato DCLWMBI Hepzato Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Thioguanine + Ixabepilone DC4M121 Ixabepilone Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Ixabepilone DCPKXJW Ixabepilone Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Ixabepilone DC8FSX8 Ixabepilone Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Ixabepilone DCVQT42 Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Ixabepilone DC9K1TN Ixabepilone Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Dactinomycin DC5KZ95 Dactinomycin Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Dactinomycin DC4UN5P Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Dactinomycin DCB51ET Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Dactinomycin DCEW6VE Dactinomycin Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Dactinomycin DC8DYIH Dactinomycin Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Dactinomycin DCB1Z4T Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [7]
Thioguanine + Dactinomycin DCMAQIM Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Dactinomycin DC8U3NF Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + Dactinomycin DCLTXRK Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [7]
Thioguanine + Dactinomycin DCR6RXZ Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [7]
Thioguanine + Dactinomycin DCFUVNL Dactinomycin Melanoma (Cell Line: SK-MEL-2) [7]
Thioguanine + Dactinomycin DCX59TO Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Dactinomycin DCV6AXN Dactinomycin Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + DFN-15 DC109BC DFN-15 Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + DFN-15 DCCKAJI DFN-15 Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + Lapatinib DCBLBID Lapatinib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Lapatinib DCQ1T2U Lapatinib Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Lapatinib DCNW6AW Lapatinib Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Lapatinib DCUZ7B5 Lapatinib Adenocarcinoma (Cell Line: HT29) [7]
Thioguanine + Lapatinib DC1YRNF Lapatinib Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Lapatinib DC4YFOI Lapatinib Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Lapatinib DC400VD Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Thioguanine + Lapatinib DCXW1QY Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Thioguanine + Lapatinib DCJX6EX Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Lapatinib DC1W0WQ Lapatinib Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Lapatinib DC1LKWS Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + PMID28460551-Compound-2 DC5GMBC PMID28460551-Compound-2 Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + PMID28460551-Compound-2 DCEWF0O PMID28460551-Compound-2 Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + PMID28460551-Compound-2 DC9OP3Z PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + PMID28460551-Compound-2 DCSCV8B PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + PMID28460551-Compound-2 DCP42FB PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [7]
Thioguanine + PMID28460551-Compound-2 DCB02CU PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Thioguanine + Crizotinib DCDMVS7 Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Thioguanine + Crizotinib DCTQPN0 Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Cyclophosphamide DCEEWLZ Cyclophosphamide Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Cyclophosphamide DCX8SEW Cyclophosphamide Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + LIAROZOLE DCXL3ML LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Methotrexate DCRZBJN Methotrexate Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Methotrexate DCPM9UD Methotrexate Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Methotrexate DC0741Z Methotrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Thioguanine + Isoniazid DC8QBLN Isoniazid Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Arsenic trioxide DC98DT6 Arsenic trioxide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Vemurafenib DCCWJMX Vemurafenib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Vemurafenib DC5OVOO Vemurafenib Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Vemurafenib DCDNH67 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Thioguanine + Vemurafenib DCHLB1H Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Plicamycin DCSXTZE Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Plicamycin DCCVVD5 Plicamycin Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Plicamycin DCBBS3R Plicamycin Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Plicamycin DC18PVF Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [7]
Thioguanine + Plicamycin DCLGJ22 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [7]
Thioguanine + Plicamycin DCM1C07 Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Plicamycin DCX2ICZ Plicamycin Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + Plicamycin DC4US7Z Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [7]
Thioguanine + Plicamycin DCWAI88 Plicamycin Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Plicamycin DCWMPLW Plicamycin Melanoma (Cell Line: MALME-3M) [7]
Thioguanine + Plicamycin DCN6AZO Plicamycin Melanoma (Cell Line: SK-MEL-2) [7]
Thioguanine + Plicamycin DCFR43N Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Plicamycin DCL2RVI Plicamycin Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Nilotinib DCEAUH9 Nilotinib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Nilotinib DCFX62K Nilotinib Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Nilotinib DCSOV4G Nilotinib Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Nilotinib DCAT66X Nilotinib Adenocarcinoma (Cell Line: HT29) [7]
Thioguanine + Nilotinib DC9HP7E Nilotinib Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Nilotinib DCZTW3J Nilotinib Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Nilotinib DC8QC76 Nilotinib Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Nilotinib DC7X1S1 Nilotinib Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Nilotinib DCW0XYP Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Nilotinib DC6OLCN Nilotinib Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Nilotinib DCBNBU1 Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + 10-hydroxycamptothecin DCHVUET 10-hydroxycamptothecin Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + 10-hydroxycamptothecin DC1O0NU 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HT29) [7]
Thioguanine + Pralatrexate DCUMTE4 Pralatrexate Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Pralatrexate DCNPZDN Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Terameprocol DC76TBJ Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + SCH 727965 DCQJ74A SCH 727965 Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + SCH 727965 DCLV9NP SCH 727965 Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + SCH 727965 DCHA01T SCH 727965 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + SCH 727965 DCODLS4 SCH 727965 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + Ifosfamide DCHJ131 Ifosfamide Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Raloxifene DCV72BJ Raloxifene Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Raloxifene DCOW43O Raloxifene Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + Bendamustine hydrochloride DCVU5CQ Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Bendamustine hydrochloride DC91AMB Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Bendamustine hydrochloride DCZ6JW7 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [7]
Thioguanine + Bendamustine hydrochloride DCI3LKH Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Bendamustine hydrochloride DCL0FQG Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [7]
Thioguanine + Bendamustine hydrochloride DC16ATG Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [7]
Thioguanine + Bendamustine hydrochloride DCV2WBN Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Sirolimus DCTP44V Sirolimus Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Letrozole DCOT3OH Letrozole Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Letrozole DCT9XYE Letrozole Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Letrozole DCCL7S4 Letrozole Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Letrozole DC8R2SI Letrozole Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Letrozole DC1VLTX Letrozole Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + Mitomycin DC7BKIW Mitomycin Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Mitomycin DCGJQGZ Mitomycin Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Mitomycin DCM4JO9 Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + SY-1425 DCTM2QE SY-1425 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + SY-1425 DCNZ2PH SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Thioguanine + Vincristine DC2BBEM Vincristine Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Vincristine DCUUJMY Vincristine Adenocarcinoma (Cell Line: OVCAR3) [7]
Thioguanine + Vincristine DC2XM9J Vincristine Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Vincristine DCL81ZA Vincristine Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + Vincristine DCJJ0K2 Vincristine Amelanotic melanoma (Cell Line: M14) [7]
Thioguanine + Vincristine DCDZ06U Vincristine Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Thioguanine + Vincristine DCDKOS1 Vincristine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Vincristine DCZJBJ8 Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Vincristine DCE9Z4Y Vincristine Malignant melanoma (Cell Line: LOX IMVI) [7]
Thioguanine + Vincristine DCMSZFP Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Vincristine DCBJ9XD Vincristine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Vincristine DC8PHJA Vincristine Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Vincristine DCSJBCD Vincristine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Thioguanine + Arfolitixorin DCXO112 Arfolitixorin Adenocarcinoma (Cell Line: OVCAR3) [7]
Thioguanine + Arfolitixorin DC5SKCB Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Arfolitixorin DCTER85 Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [7]
Thioguanine + Arfolitixorin DCKJT66 Arfolitixorin Melanoma (Cell Line: SK-MEL-2) [7]
Thioguanine + Arfolitixorin DCX3ZIT Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Altretamine DCIG9X6 Altretamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + TEM DC6ZMJP TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + TEM DCOTFBY TEM Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + JNK-IN-8 DCVIEMP JNK-IN-8 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + Imatinib DC9ZH7X Imatinib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Imatinib DCSA1CZ Imatinib Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Imatinib DC3NEL3 Imatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Bleomycin DC7UKFJ Bleomycin Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Bleomycin DCDFWO9 Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [7]
Thioguanine + Bleomycin DCSBA0G Bleomycin Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Bleomycin DC1QN5C Bleomycin Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Bleomycin DC2ZSQ2 Bleomycin Adenocarcinoma (Cell Line: HT29) [7]
Thioguanine + Bleomycin DCK8G02 Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Bleomycin DCRGTTJ Bleomycin Melanoma (Cell Line: MALME-3M) [7]
Thioguanine + Bleomycin DCUAXJL Bleomycin Melanoma (Cell Line: UACC-257) [7]
Thioguanine + Bleomycin DCG67TU Bleomycin Melanoma (Cell Line: SK-MEL-2) [7]
Thioguanine + Bleomycin DCD7ES7 Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Bortezomib DC9U5WT Bortezomib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Bortezomib DCMHTLC Bortezomib Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Bortezomib DC80N9N Bortezomib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Bortezomib DCIUQ15 Bortezomib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + Valrubicin DCZNRUP Valrubicin Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Topotecan DCWL6X1 Topotecan Adenocarcinoma (Cell Line: OVCAR3) [7]
Thioguanine + Topotecan DCTCS5J Topotecan Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Topotecan DCZ7OV1 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [7]
Thioguanine + Topotecan DCW6GEV Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [7]
Thioguanine + Topotecan DCQE82K Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Thioguanine + Topotecan DCGGG08 Topotecan Lung adenocarcinoma (Cell Line: EKVX) [7]
Thioguanine + Topotecan DCSLZDJ Topotecan Melanoma (Cell Line: UACC-257) [7]
Thioguanine + Topotecan DCCFPN8 Topotecan Melanoma (Cell Line: MALME-3M) [7]
Thioguanine + Topotecan DCYA3PP Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Topotecan DCO76B7 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Thioguanine + Topotecan DC5W0CI Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Thioguanine + Cisplatin DCEDMIW Cisplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Chlorambucil DCLTOFJ Chlorambucil Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Chlorambucil DCECL80 Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [7]
Thioguanine + Sorafenib DCIHRHJ Sorafenib Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Sorafenib DCLEJOQ Sorafenib Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + ER819762 DCKP76Q ER819762 Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + ER819762 DCFU2M6 ER819762 Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + ER819762 DCF6FN2 ER819762 Adenocarcinoma (Cell Line: HT29) [7]
Thioguanine + ER819762 DCHNMKL ER819762 Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + ER819762 DCGS3J6 ER819762 Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + ER819762 DCBFQ9G ER819762 Adenocarcinoma (Cell Line: HCT-15) [7]
Thioguanine + ER819762 DCJZ45J ER819762 Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + Romidepsin DCB92I8 Romidepsin Amelanotic melanoma (Cell Line: MDA-MB-435) [7]
Thioguanine + Romidepsin DCK5N87 Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [7]
Thioguanine + Romidepsin DCPBU6U Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [7]
Thioguanine + Romidepsin DCXHW4P Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Thioguanine + Romidepsin DCM3QT7 Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [7]
Thioguanine + Romidepsin DCT2N7S Romidepsin Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Romidepsin DC985B4 Romidepsin Melanoma (Cell Line: MALME-3M) [7]
Thioguanine + Romidepsin DC8EZ96 Romidepsin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Azacitidine DCCQ67S Azacitidine Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Azacitidine DCPFTJX Azacitidine Cutaneous melanoma (Cell Line: SK-MEL-28) [7]
Thioguanine + Azacitidine DCULFFL Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Pomalidomide DC8JQT4 Pomalidomide Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Pomalidomide DC4R8AJ Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [7]
Thioguanine + Pomalidomide DCRFQ2P Pomalidomide Lung adenocarcinoma (Cell Line: EKVX) [7]
Thioguanine + Pomalidomide DCHZ699 Pomalidomide Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Pomalidomide DC4N13L Pomalidomide Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Mercaptopurine DC7CYMZ Mercaptopurine Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Mercaptopurine DCE81J7 Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Mepacrine DC8YCHE Mepacrine Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Mepacrine DCW5UCM Mepacrine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Taxol DCUN53M Taxol Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Taxol DCMSTKR Taxol Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + PMID28870136-Compound-43 DCY6EP5 PMID28870136-Compound-43 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + PMID28870136-Compound-43 DCEFXL0 PMID28870136-Compound-43 Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + FORMESTANE DCWTRQ5 FORMESTANE Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + FORMESTANE DCFJ487 FORMESTANE Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + FORMESTANE DCM7I9J FORMESTANE Prostate carcinoma (Cell Line: PC-3) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCFQOFL Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: DU-145) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCMKSER Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCBR7KS Aminolevulinic Acid Hydrochloride Amelanotic melanoma (Cell Line: MDA-MB-435) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCCBGPY Aminolevulinic Acid Hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DC0PDLZ Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCO59D2 Aminolevulinic Acid Hydrochloride Lung adenocarcinoma (Cell Line: EKVX) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCZX7N9 Aminolevulinic Acid Hydrochloride Malignant melanoma (Cell Line: LOX IMVI) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DC3X18O Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: SK-MEL-2) [7]
Thioguanine + Aminolevulinic Acid Hydrochloride DCXQ3EN Aminolevulinic Acid Hydrochloride Non-small cell lung carcinoma (Cell Line: HOP-92) [7]
Thioguanine + Estramustine DCHNIAX Estramustine Adenocarcinoma (Cell Line: OVCAR3) [7]
Thioguanine + Estramustine DCXRL8J Estramustine Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Estramustine DCUAHNB Estramustine Adenocarcinoma (Cell Line: A549) [7]
Thioguanine + Digitoxin DCT7LTX Digitoxin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Busulfan DCAV18O Busulfan Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Busulfan DCQVAJG Busulfan Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Busulfan DC77SEC Busulfan Adenocarcinoma (Cell Line: HCT116) [7]
Thioguanine + Busulfan DCRK05Z Busulfan Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Busulfan DCCL7UT Busulfan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [7]
Thioguanine + Dasatinib DCFS8FU Dasatinib Adenocarcinoma (Cell Line: NCIH23) [7]
Thioguanine + Dasatinib DCX5GX1 Dasatinib Adenocarcinoma (Cell Line: SW-620) [7]
Thioguanine + Dasatinib DC5693D Dasatinib Adenocarcinoma (Cell Line: HCC-2998) [7]
Thioguanine + Dasatinib DC5U9YL Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Thioguanine + Dasatinib DCK83FV Dasatinib Large cell lung carcinoma (Cell Line: NCI-H460) [7]
Thioguanine + Dasatinib DCV9LKC Dasatinib Lung adenocarcinoma (Cell Line: HOP-62) [7]
Thioguanine + Dasatinib DCTDHKH Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [7]
Thioguanine + Dasatinib DCUU397 Dasatinib Malignant melanoma (Cell Line: UACC62) [7]
Thioguanine + Dasatinib DC05SG8 Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Thioguanine + Dasatinib DCZC05B Dasatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [7]
Trifluridine + Thioguanine DCNOB48 Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Trifluridine + Thioguanine DCSK2FP Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Trifluridine + Thioguanine DCKNRZ6 Trifluridine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Trifluridine + Thioguanine DCU0WIH Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Uracil mustard + Thioguanine DCU0BGK Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Uracil mustard + Thioguanine DCJ7O5G Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [5]
Uracil mustard + Thioguanine DC5XSIZ Uracil mustard Astrocytoma (Cell Line: SNB-19) [5]
Uracil mustard + Thioguanine DCFIUMX Uracil mustard Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Uracil mustard + Thioguanine DCQ1OP1 Uracil mustard Glioma (Cell Line: SF-295) [5]
Uracil mustard + Thioguanine DC3OHS7 Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Uracil mustard + Thioguanine DCMISZF Uracil mustard Carcinoma (Cell Line: RXF 393) [6]
Uracil mustard + Thioguanine DCYZHEC Uracil mustard Lung adenocarcinoma (Cell Line: EKVX) [7]
Uracil mustard + Thioguanine DCB126I Uracil mustard Melanoma (Cell Line: SK-MEL-2) [7]
Vandetanib + Thioguanine DCH2LA1 Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Vandetanib + Thioguanine DCMRAUT Vandetanib Colon carcinoma (Cell Line: KM12) [6]
Vandetanib + Thioguanine DCPCLRE Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [6]
Vandetanib + Thioguanine DCFL2UT Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Vandetanib + Thioguanine DCUQXKL Vandetanib Adenocarcinoma (Cell Line: DU-145) [7]
Vandetanib + Thioguanine DCFOR1P Vandetanib Adenocarcinoma (Cell Line: NCIH23) [7]
Vandetanib + Thioguanine DCJLPP4 Vandetanib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [7]
Vandetanib + Thioguanine DCSDH0C Vandetanib Amelanotic melanoma (Cell Line: MDA-MB-435) [7]
Vandetanib + Thioguanine DCJBO0K Vandetanib Astrocytoma (Cell Line: U251) [7]
Vandetanib + Thioguanine DCUBY3T Vandetanib Astrocytoma (Cell Line: SNB-19) [7]
Vandetanib + Thioguanine DCINM2H Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [7]
Vandetanib + Thioguanine DC3QS4G Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [7]
Vandetanib + Thioguanine DC9M9E4 Vandetanib Glioma (Cell Line: SF-295) [7]
Vandetanib + Thioguanine DCSXO09 Vandetanib Glioma (Cell Line: SF-268) [7]
Vandetanib + Thioguanine DC9KJ71 Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Vandetanib + Thioguanine DCV2SS6 Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Vandetanib + Thioguanine DCGRZFS Vandetanib Lung adenocarcinoma (Cell Line: EKVX) [7]
Vandetanib + Thioguanine DCCZR9X Vandetanib Lung adenocarcinoma (Cell Line: MDA-MB-231) [7]
Vandetanib + Thioguanine DCQIAYL Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [7]
Vandetanib + Thioguanine DCGC856 Vandetanib Papillary renal cell carcinoma (Cell Line: ACHN) [7]
Vandetanib + Thioguanine DCLKLWO Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [7]
Vandetanib + Thioguanine DCRP00L Vandetanib Renal cell carcinoma (Cell Line: SN12C) [7]
Vemurafenib + Thioguanine DCQR9IC Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Vemurafenib + Thioguanine DCW8OW1 Vemurafenib Carcinoma (Cell Line: RXF 393) [6]
Vemurafenib + Thioguanine DC5UC31 Vemurafenib Carcinoma (Cell Line: MCF7) [6]
Vemurafenib + Thioguanine DCANGXD Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [6]
Vemurafenib + Thioguanine DCJZS8T Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [6]
Vemurafenib + Thioguanine DCYSPML Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [6]
Vemurafenib + Thioguanine DCNPQSN Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [6]
Vemurafenib + Thioguanine DCB2BQ4 Vemurafenib Adenocarcinoma (Cell Line: DU-145) [7]
Vemurafenib + Thioguanine DCVCSDD Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [7]
Vemurafenib + Thioguanine DCVJGOT Vemurafenib Astrocytoma (Cell Line: U251) [7]
Vemurafenib + Thioguanine DCLL0E6 Vemurafenib Astrocytoma (Cell Line: SNB-19) [7]
Vemurafenib + Thioguanine DC2WI1N Vemurafenib Chronic myelogenous leukemia (Cell Line: K-562) [7]
Vemurafenib + Thioguanine DC5FT5P Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [7]
Vemurafenib + Thioguanine DCPQ4N4 Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [7]
Vemurafenib + Thioguanine DCMCAMO Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [7]
Vemurafenib + Thioguanine DC5QA30 Vemurafenib Glioblastoma (Cell Line: SNB-75) [7]
Vemurafenib + Thioguanine DC8DZL7 Vemurafenib Glioma (Cell Line: SF-295) [7]
Vemurafenib + Thioguanine DCJ5CCN Vemurafenib Glioma (Cell Line: SF-539) [7]
Vemurafenib + Thioguanine DCGF7QX Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [7]
Vemurafenib + Thioguanine DC8T9WI Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [7]
Vemurafenib + Thioguanine DCVTBS0 Vemurafenib Lung adenocarcinoma (Cell Line: EKVX) [7]
Vemurafenib + Thioguanine DCTYLNY Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [7]
Vemurafenib + Thioguanine DC2G8CE Vemurafenib Melanoma (Cell Line: UACC-257) [7]
Vemurafenib + Thioguanine DCTIEM3 Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [7]
Vemurafenib + Thioguanine DCSHACK Vemurafenib Papillary renal cell carcinoma (Cell Line: ACHN) [7]
Vemurafenib + Thioguanine DCKTI38 Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [7]
Vemurafenib + Thioguanine DCFRRS4 Vemurafenib Renal cell carcinoma (Cell Line: SN12C) [7]
Vismodegib + Thioguanine DCNFSXF Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [6]
Vismodegib + Thioguanine DCXIU5B Vismodegib Carcinoma (Cell Line: RXF 393) [6]
Vismodegib + Thioguanine DCO6FXE Vismodegib Adenocarcinoma (Cell Line: DU-145) [7]
Vismodegib + Thioguanine DC6WXT1 Vismodegib Astrocytoma (Cell Line: SNB-19) [7]
Vismodegib + Thioguanine DC0ZPHV Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [7]
Vismodegib + Thioguanine DC9QP16 Vismodegib Glioma (Cell Line: SF-295) [7]
Vismodegib + Thioguanine DCXLVZC Vismodegib Lung adenocarcinoma (Cell Line: HOP-62) [7]
Vismodegib + Thioguanine DCJRVQM Vismodegib Renal cell carcinoma (Cell Line: SN12C) [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 821 DrugCom(s)
4 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Thioguanine + Procarbazine DCZBFOJ Procarbazine Brain Tumors [8]
Celecoxib + Thioguanine DC33LBO Celecoxib Anaplastic Glioma of Brain [9]
Celecoxib + Thioguanine DCVZ25T Celecoxib Anaplastic Glioma of Brain [9]
Methotrexate + Thioguanine DCWQ945 Methotrexate Hodgkin's Disease [10]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Thioguanine FDA Label
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6845).
4 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res. 2015 Mar;115:9-16.
5 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
6 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
7 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
8 ClinicalTrials.gov (NCT00002944) Combination Chemotherapy in Treating Children With Progressive Brain Tumors
9 ClinicalTrials.gov (NCT00504660) 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
10 ClinicalTrials.gov (NCT00587873) Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)